Skip to Content
Merck

1.02776

SAFC

Trehalose dihydrate

EMPROVE® EXPERT, Ph. Eur., ChP, NF, JP

Pharma Manufacturing

Synonym(s):

D-(+)-Trehalose dihydrate, 1-O-alpha-D-Glucopyranosyl-alpha-D-glucopyranoside, α,α-Trehalose, α-D-Glucopyranosyl-α-D-glucopyranoside

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C12H22O11 · 2H2O
CAS Number:
Molecular Weight:
378.33
Beilstein:
5322018
MDL number:
UNSPSC Code:
12352201
EC Index Number:
202-739-6
Pricing and availability is not currently available.

Agency

ChP
JP
NF
Ph. Eur.

Quality Level

product line

EMPROVE® EXPERT

form

solid

feature

RNase and DNase free

mp

96.5-97.5 °C

application(s)

liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical
semi-solid formulation

storage temp.

no temp limit

SMILES string

[H]O[H].[H]O[H].OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

InChI

1S/C12H22O11.2H2O/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12;;/h3-20H,1-2H2;2*1H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-;;/m1../s1

InChI key

DPVHGFAJLZWDOC-PVXXTIHASA-N

Looking for similar products? Visit Product Comparison Guide

General description

Chemicals play an important role in the stabilization of a biologic drug during its manufacturing and formulation process – for instance, by preventing aggregation. We offer a wide range of high-quality stabilizers, buffers and salts to successfully purify and formulate your biomolecules. Specifically developed for high-risk applications, they are low in bioburden and endotoxins.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Trehalose is widely used in biomolecule formulation as a stabilizing agent.
Trehalose dihydrate Emprove® Expert is low in endotoxins and bioburden, making it the right choice for your high-risk applications.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


What is the Emprove® Program?

The Emprove® Program is a system providing comprehensive and thorough documentation of our filters and single-use components, pharma raw materials, and starting materials. Four document types are included with an Emprove® Program subscription:

Material Qualification Dossier

Free of charge - Sign in to download

Quality Management Dossier (Open Access)

Free of charge - Sign in to download

Quality Management Dossier (Open Access)

Free of charge - Sign in to download

Operational Excellence Dossier

Available by subscription or for a fee

Operational Excellence Dossier

Available by subscription or for a fee

Learn more about the benefits an Emprove® Program subscription can provide
Why are these documents unavailable?
Emprove® Dossiers contain information intended to support the registration process and risk assessment activities of pharmaceutical producers and contain confidential information. Please contact us if you would like access.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.

This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.

This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.

This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.

See All

Related Content

Learn more on mAb subcutaneous or intravenous formulation, and the relevant associated products, including excipients.

Learn more on mAb subcutaneous or intravenous formulation, and the relevant associated products, including excipients.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service